Can wearable sensors unlock better blood sugar control after kidney transplants?

NCT ID NCT06675903

NEW Recruiting now Knowledge-focused Sponsor: Bo Feldt-Rasmussen Source: ClinicalTrials.gov ↗

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This study uses continuous glucose monitors (CGMs) to track blood sugar levels in the days right after a kidney transplant. It compares three groups of recipients: those with diabetes, those with pre-diabetes, and those without diabetes. The goal is to see if glucose patterns differ between these groups, which could help tailor post-transplant care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: continuous glucose monitoring (CGM)
What this could lead to: If successful, this could improve how blood sugar is managed after kidney transplantation, potentially leading to better outcomes and fewer complications.
What could go wrong: This is a small, observational study, so results may not apply to all transplant patients. It does not test a treatment, so it cannot directly change care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERGLYCAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hyperglycemia prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERGLYCAEMIA KIDNEY TRANSPLANTATION

Contacts and locations

Locations

Rigshospitalet
RECRUITING

Copenhagen, DK, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.